Not Yet RecruitingNot Applicable

Effects of a Protocol of Hip Flexor Stretching on Chronic Mechanical, Non-specific LBP.

Poland100 participantsStarted 2025-07-02

Plain-language summary

The goal of this clinical trial is to compare the effectiveness of a stretching, exercise and education protocol versus usual care in improving pain, function and disability in patients with non-specific mechanical chronic low back pain (CLBP). The research hypothesis is: A combination of hip flexors stretching, exercise and education is more effective than usual care to improve pain, function and disability in patients with CLBP. Participants will be randomly allocated in one of the two treatment groups. Pain, function and disability will be assessed before starting treatment, after the end of the treatment and one month , three months and one year after the end of the treatment.

Who can participate

Age range18 Years – 75 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Age 18-75 years * Medical diagnosis of chronic, mechanical, non-specific pain in the lumbar spine (M54, M51) - chronic low back pain. * Obtaining written consent to conduct research * Must be able to swallow tablets Exclusion Criteria: * Pregnancy * Pacemaker * Active cancer * To consent to conduct research * Difficulty communicating * The presence of a metal plate in the head and metal screws in the body * Condition after operations in the area of the lumbar spine * Condition after fractures in the lumbar spine * Contraindications to manual therapy or exercise * Has participated in a lumbar spine exercise or manual therapy program in the last three months * Present clear signs of having suffered a significant lumbar injury * Inability to maintain standing or a supine or prone position * No possibility to perform the stretching of hip flexors

What they're measuring

Numeric Pain Rating Scale (NPRS)

Timeframe: Baseline, to complete the treatments, on average 2 weeks, 1, 3 and 12 months after the end of treatment

Trial details

NCT IDNCT06975345

SponsorWroclaw University of Health and Sport Sciences

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2026-12-31

Contact for this trial

Aleksander Kucza